HomeLBTSF • OTCMKTS
add
Almirall SA
Previous close
$9.51
Year range
$9.00 - $9.51
Market cap
1.92B EUR
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 251.28M | 7.05% |
Operating expense | 205.96M | 19.31% |
Net income | 7.99M | 85.17% |
Net profit margin | 3.18 | 72.83% |
Earnings per share | — | — |
EBITDA | 44.11M | -11.61% |
Effective tax rate | 47.34% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 330.88M | -26.03% |
Total assets | 2.32B | -0.79% |
Total liabilities | 834.81M | 1.98% |
Total equity | 1.49B | — |
Shares outstanding | 213.47M | — |
Price to book | 1.37 | — |
Return on assets | 1.89% | — |
Return on capital | 2.35% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 7.99M | 85.17% |
Cash from operations | 42.91M | -23.24% |
Cash from investing | -70.02M | 44.79% |
Cash from financing | -7.84M | -104.12% |
Net change in cash | -34.95M | -129.30% |
Free cash flow | -78.74M | -640.92% |
About
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Founded
1944
Website
Employees
1,996
